To whom correspondence should be addressed; Institute of Cognitive Neuroscience, University College, 17 Queen Square, London, WC1N 3AR, UK; tel: +44-207-679-1170, fax: +44-207-679-1121, e-mail:
Schizophr Bull. 2013 Nov;39(6):1328-36. doi: 10.1093/schbul/sbs147. Epub 2012 Dec 12.
The "aberrant salience" model proposes that psychotic symptoms first emerge when chaotic brain dopamine transmission leads to the attribution of significance to stimuli that would normally be considered irrelevant. This is thought to occur during the prodromal phase of psychotic disorders, but this prediction has not been tested previously. In the present study, we tested this model in 18 healthy volunteers and 18 unmedicated individuals at ultra-high risk of psychosis. Subjects performed the Salience Attribution Test, which provides behavioral measures of adaptive and aberrant motivational salience, during functional magnetic resonance imaging to assess neural responses to relevant and irrelevant stimulus features. On a separate occasion, the same subjects were also studied with [(18)F]fluorodopa positron emission tomography to measure dopamine synthesis capacity. Individuals at ultra-high risk of psychosis were more likely to attribute motivational salience to irrelevant stimulus features (t(26.7) = 2.8, P = .008), and this bias was related to the severity of their delusion-like symptoms (r = .62, P = .008). Ventral striatal responses to irrelevant stimulus features were also correlated with delusion-like symptoms in the ultra-high risk group (r = .59, P = .017). Striatal dopamine synthesis capacity correlated negatively with hippocampal responses to irrelevant stimulus features in ultra-high risk individuals, but this relationship was positive in controls. These data are consistent with the hypothesis that aberrant salience processing underlies psychotic symptoms and involves functional alterations in the striatum, hippocampus, and the subcortical dopamine system.
“异常突显”模型提出,当混乱的大脑多巴胺传递导致对通常被认为不相关的刺激赋予意义时,精神病症状首先出现。这被认为发生在精神病障碍的前驱期,但这一预测以前没有得到过检验。在本研究中,我们在 18 名健康志愿者和 18 名未接受药物治疗的精神病超高风险个体中测试了这一模型。受试者在功能磁共振成像期间执行突显归因测试,该测试提供了适应性和异常动机突显的行为测量,以评估对相关和不相关刺激特征的神经反应。在另一个场合,相同的受试者还接受了 [(18)F]氟多巴正电子发射断层扫描,以测量多巴胺合成能力。精神病超高风险个体更有可能将动机突显归因于不相关的刺激特征(t(26.7) = 2.8,P =.008),这种偏差与他们类似妄想症状的严重程度有关(r =.62,P =.008)。无关刺激特征的腹侧纹状体反应与超高风险组的类似妄想症状也相关(r =.59,P =.017)。纹状体多巴胺合成能力与超高风险个体对无关刺激特征的海马体反应呈负相关,但在对照组中这种关系是正相关的。这些数据与以下假设一致,即异常突显处理是精神病症状的基础,涉及纹状体、海马体和皮质下多巴胺系统的功能改变。
Schizophr Bull. 2012-12-12
Schizophr Bull. 2016-1
Neuropsychobiology. 2012-7-13
Riv Psichiatr. 2015
Schizophr Res. 2015-8
Front Pharmacol. 2025-7-1
Schizophr Bull Open. 2023-8-24
Mol Psychiatry. 2024-12
Mol Psychiatry. 2012-8-7
Am J Psychiatry. 2011-7-18
Int J Neuropsychopharmacol. 2011-2-18
Arch Gen Psychiatry. 2010-12
Neuroimage. 2009-12-5
Neuropsychopharmacology. 2009-8-12
Psychopharmacology (Berl). 2009-5-28